Neurology
Found 9 results
Filters: Author is Kaunzner, Ulrike  [Clear All Filters]
2024
Michaelson NMiriam, Langan D, Kaunzner U.  2024.  FLAIR-Hyperintense Lesions in Anti-MOG-Associated Encephalitis With Seizures (FLAMES).. Neurohospitalist. 14(2):222-223.
2023
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Tozlu C, Olafson E, Jamison KW, Demmon E, Kaunzner U, Marcille M, Zinger N, Michaelson N, Safi N, Nguyen T et al..  2023.  The sequence of regional structural disconnectivity due to multiple sclerosis lesions.. Brain Commun. 5(6):fcad332.
Tozlu C, Olafson E, Jamison K, Demmon E, Kaunzner U, Marcille M, Zinger N, Michaelson N, Safi N, Nguyen T et al..  2023.  The sequence of regional structural disconnectivity due to multiple sclerosis lesions.. bioRxiv.
2021
Tozlu C, Jamison K, Nguyen T, Zinger N, Kaunzner U, Pandya S, Wang Y, Gauthier S, Kuceyeski A.  2021.  Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis.. Brain Behav. 11(10):e2353.
2018
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.  2018.  Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.. Mult Scler. 24(4):540-542.
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.  2018.  Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.. Mult Scler. 24(4):553-554.
2016
Jacoby N, Kaunzner U, Dinkin M, Safdieh J.  2016.  Diagnosing RCVS Without the CV: The Evolution of Reversible Cerebral Vasoconstriction Syndrome.. Neurohospitalist. 6(3):NP1-4.
Merkler AE, Duggal I, Kaunzner U, Maciel CB, Miller AM, Scognamiglio T, Dinkin MJ.  2016.  Rapidly progressive bilateral optic nerve and retinal infarctions due to rhinocerebral mucormycosis and pseudoephedrine use.. Neurol Clin Pract. 6(6):549-552.